AMYPAD features prominently at AAIC2021

The 2021 Alzheimer’s Association International Conference (AAIC) took place from 26-30 July as a hybrid event (online and in the city of Denver, US).

More than 12,000 registered attendees from over 110 countries joined the meeting to discuss the latest studies, theories and discoveries that will help bring the world closer to breakthroughs in dementia science. Please visit the AAIC 2021 website to learn more about the research findings and discoveries that were shared by researchers from around the globe.

Lyduine Collij gave an inspiring presentation entitled “Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals” (Hybrid Oral Session #55409). This study investigated the longitudinal trajectory of global and regional Aβ measurements and their value in predicting cognition in initially cognitively unimpaired subjects.

We are also pleased that six AMYPAD abstracts were accepted for poster presentation:

“Data-driven evidence for three distinct patterns of amyloid-β accumulation”, Lyduine Collij (Poster #55417)
“Test-retest variability of relative tracer delivery rate as measured by [11C]PiB”, Fiona Heeman (Poster #51654)
“Optimal parametric imaging methods for dual-time-window [18F]flutemetamol and [18F]florbetaben PET studies”, Fiona Heeman (Poster #51683)
“Current Status and Quantitative Results of the AMYPAD Prognostic and Natural History Study”, Juan Domingo Gispert (Poster #55540)
“Evaluating robustness of the Centiloid scale against variations in amyloid PET image resolution”, Mahnaz Shekari (Poster #55726)
“Quantitative Amyloid PET in the AMYPAD Diagnostic and Patient Management Study”, Chris Buckley (Poster #55940)

In addition, Valentina Garibotto and Giovanni Frisoni presented some cases from the AMYPAD Diagnostic and Patient Management Study. Their presentation is available in the Product Theatre tab “Neurology and Nuclear Medicine; working together for an optimal dementia diagnosis”.

We would like to congratulate Arianna Sala who received the “de Leon Prize in Neuroimaging” for her work entitled “Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity”. This paper was published in the journal Molecular Psychiatry, you can read it here. This work was conducted within the AMYPAD project.

The AMYPAD team had the opportunity to present different aspects of our project and discuss results. If you were registered for AAIC and missed the above presentations, please note that all of these presentations are available on-demand until August 29, 2021. If you have missed the event, do not hesitate to download the AMYPAD posters on our website here.

—

Receive the latest news. Click here to subscribe!